AKT1 and chondrosarcoma: Given that EGFR activation triggers known oncogenic signals such as ERK1/2 and AKT and promote malignant phenotype, we analyzed the activation status of these pathways in HEMC-SS and SW1353 chondrosarcoma cells, and in human primary chondrocytes.